Archive for the ‘Cell Therapy’ Category

Stem Cell Therapy Treatment for Spino Muscular Atrophy by Dr Alok Sharma, Mumbai, India
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Spino Muscular Atrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Stamina has improved. 2. Fatigue is...

By: Neurogen Brain and Spine Institute

Originally posted here:
Stem Cell Therapy Treatment for Spino Muscular Atrophy by Dr Alok Sharma, Mumbai, India - Video

Stem Cell Therapy Treatment for Cerebellar Ataxia by Dr Alok Sharma, Mumbai, India
Improvement seen in just 3 Months after Stem Cell Therapy Treatment for Cerebellar Ataxia by Dr Alok Sharma, Mumbai, India. Stem Cell Therapy done at Dr Alok...

By: Neurogen Brain and Spine Institute

More here:
Stem Cell Therapy Treatment for Cerebellar Ataxia by Dr Alok Sharma, Mumbai, India - Video

Stem Cell Therapy Treatment for Autism with MR by Dr Alok Sharma, Mumbai, India
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Autism with MR by Dr Alok Sharma, Mumbai, India After Stem Cell Therapy 1. Her sitting tolerance has improved from 15...

By: Neurogen Brain and Spine Institute

Read this article:
Stem Cell Therapy Treatment for Autism with MR by Dr Alok Sharma, Mumbai, India - Video

Orange, CA (PRWEB) September 17, 2013

The top regenerative medicine clinic in Southern California, TeleHealth, is now offering stem cell therapy for back pain due to degenerative disc disease. The treatment has the potential to repair and regenerate damaged spinal discs and is performed as an outpatient procedure. For more information and scheduling, call (888) 828-4575.

One of the most troublesome spinal conditions to treat has been degenerative disc disease. Normally, a spinal disc contains 80% water. However, as it degenerates that percentage decreases and the discs are not great at regenerating themselves. This degeneration may unfortunately happen at a young age due to genetics or post traumatic deterioration.

TeleHealth, the leading stem cell therapy clinic in California, is now offering regenerative medicine treatments for degenerative disc disease. This includes either platelet rich plasma therapy (PRP), bone marrow derived stem cell injections, fat derived stem cell injections or a combination of therapies.

The treatments are on the cutting edge of medicine and have brought home to millions of individuals suffering from degenerative arthritis, disc disease and soft tissue injuries. TeleHealth also provides stem cell injections for osteoarthritis, rotator cuff tendonitis, achilles tendonitis, tennis elbow, ligament sprains and new indications such as hair loss and breast reconstruction after cancer.

The essential problem is that the metabolism of the degenerative disc is too slow and not able to heal itself. Stem cell treatments bring in vital reparative cells to the area along with growth factors to spur healing. The stem cell treatments for degenerative disc disease are not covered by insurance, however, most other treatments are at TeleHealth.

The treatments are all outpatient and offered by Board Certified doctors. For more information and scheduling of stem cell treatments for disc disease, call (888) 828-4575.

See more here:
Southern California Regenerative Medicine Clinics Now Offering Stem Cell Therapy for Degenerative Disc Disease and ...

Poway, California (PRWEB) September 12, 2013

The Arrow Group of Animal Hospitals, out of Glendale, Arizona and their 17 Phoenix Metro area veterinary hospitals have partnered with California based Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company, to bring stem cell therapy to their patients. Dogs that are suffering pain or inflammation from osteoarthritis or polyarthritis, joint or ligament issues, or muscle injuries, can now receive stem cell therapy.

The Arrow Group of Animal Hospitals hosted Vet-Stems Corey Orava, DVM for a week of training sessions to help all of their staff learn the ins and outs of stem cell therapy. Veterinarians and technicians benefited from hands-on labs and a continuing education course that will help them bring the best care to their patients and pet owners. Under the mentorship of Dr. Orava Dobson Ranch Animal Hospital, Fletcher Heights Animal Hospital, Surprise Animal Hospital and Animal Hospital at Anthem were able to perform their debut stem cell therapy cases during their initial week of offering the new service.

The Arrow Group of Animal Hospitals is a co-operative group of 17 individual small animal hospitals around the valley that are proud to offer the highest quality veterinary care possible. The doctors and staff at each hospital strive to build a long term relationship with their client families and their pets, always making recommendations in the pets best health interest. The Arrow Group of Animal Hospitals offer complete veterinary care from wellness, to vaccines, spays and neuters, dental, surgical and now regenerative medicine. Their animal hospital locations can be easily found at http://www.azpetvet.com.

About Vet-Stem, Inc. Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Original post:
The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to ...

Interview with Mr. Rene Sarmiento of Powermax Re Stem Cell Therapy Summit

By: Fritz Capulong

Read the original post:
Interview with Mr. Rene Sarmiento of Powermax Re Stem Cell Therapy Summit - Video

Interview with Mr. Rene Sarmiento of Powermax Re Stem Cell Therapy Summit Part 2

By: Fritz Capulong

Read this article:
Interview with Mr. Rene Sarmiento of Powermax Re Stem Cell Therapy Summit Part 2 - Video

Cord Blood Stem Cell Therapy and Cord Blood Banking in Thailand UCB Cells
Cord blood refers to blood left in the umbilical cord after birth. More:http://stemcellthailand.org/cord-blood-stem-cell-therapy-ucb-banking/ Back in the day...

By: Stem Cell Regeneration Center of Thailand

Original post:
Cord Blood Stem Cell Therapy and Cord Blood Banking in Thailand UCB Cells - Video

The Doctors - Stem Cell Therapy For Red The Dog
Stemcellvet.co.uk offer adipose derived Stem Cell Therapy for pets in the UK. We treat cats and dogs predominantly for arthritis but there is also the potent...

By: stemcellvet.co.uk

Read more:
The Doctors - Stem Cell Therapy For Red The Dog - Video

Stem Cell Therapy Treatment for Peripheral Neuropathy by Dr Alok Sharma Mumbai India
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Neuropathy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Cramp...

By: Neurogen Brain and Spine Institute

Read more here:
Stem Cell Therapy Treatment for Peripheral Neuropathy by Dr Alok Sharma Mumbai India - Video

MS Video (before stem cell therapy)
Raising money to get to Panama.

By: jo80hanna

See more here:
MS Video (before stem cell therapy) - Video

Short video of Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr Alok Sharma
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Limb Girdle Muscular by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Num...

By: Neurogen Brain and Spine Institute

View original post here:
Short video of Stem Cell Therapy Treatment for Limb Girdle Muscular Dystrophy by Dr Alok Sharma - Video

Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India
Improvement seen in just 6 months after Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Earli...

By: Neurogen Brain and Spine Institute

Original post:
Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India - Video

Short video on Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma Mumbai India
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. He ca...

By: Neurogen Brain and Spine Institute

Here is the original post:
Short video on Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma Mumbai India - Video

Short video of Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma Mumbai
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Dee...

By: Neurogen Brain and Spine Institute

Read this article:
Short video of Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma Mumbai - Video

Short video of Stem Cell Therapy Treatment for Cerebellar Atrophy by Dr Alok Sharma Mumbai India
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Cerebral Atrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ball throw...

By: Neurogen Brain and Spine Institute

Read the original here:
Short video of Stem Cell Therapy Treatment for Cerebellar Atrophy by Dr Alok Sharma Mumbai India - Video

Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma. He is a known case of MD with history of gradual onset of progressive lower extremities...

By: Neurogen Brain and Spine Institute

Read more here:
Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma - Video

Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: Neurogen Brain and Spine Institute

See the original post here:
Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy - Video

Short video on Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma Mumbai
Improvement seen after Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. His neck and...

By: Neurogen Brain and Spine Institute

Excerpt from:
Short video on Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma Mumbai - Video

Stem cell therapy treats animal ailments, vets see improvement
Stem cell therapy is typically tied to controversy but now, some Southern Arizona veterinarians are turning to a different form of the cutting edge treatment...

By: kgun9

View post:
Stem cell therapy treats animal ailments, vets see improvement - Video

By: Jet Villa, InterAksyon.com August 20, 2013 3:45 PM

InterAksyon.com The online news portal of TV5

MANILA, Philippines Reminder for those who wish to have their stem cell therapy practice and products accredited: You have until August 31 to register, the Department of Health said Tuesday.

Citing Administrative Order 2013-0012 issued March 18 this year, Health Secretary Enrique Ona said that while the Department of Health (DOH) supports scientific advancement in the field of cellular medicine, its priority is to protect the public from harm rather than give a blanket endorsement of its use or potential benefits.

Those who need to seek accreditation include: health care facilities doing stem cell therapy (with the DOH) as well as companies that import, market, and produce stem cell products (with the Food and Drug Administration, which is under DOH).

Ona said the DOH seeks to regulate stem cell therapy both as a recognized treatment modality and for research purposes.

"This is to allay fears that unscrupulous individuals or groups will engage in unethical practices and subject naive patients to undue harm and unproven medical claims," he added.

Among the DOH guidelines are:

Ona conceded that there are only a limited number of medical conditions in which stem cell therapy may be indicated.

Others are claims that should be taken with a grain of salt, he said.

Follow this link:
REMINDER | Stem-cell therapy accreditation deadline is Aug. 31 - DOH

Stem Cell Therapy: Where #39;s the Evidence?
Dr. Tony Dans of the University of the Philippines College of Medicine discusses dilemmas in research and regulation of stem cell therapy in the Philippines....

By: Antonio Dans

Read more:
Stem Cell Therapy: Where's the Evidence? - Video

ALAMEDA, Calif.--(BUSINESS WIRE)--

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will give the keynote address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine conference on Monday, August 19, 2013, at 12:15 p.m. EDT in Cleveland, Ohio. Dr. West will discuss the potential use of embryonic mesenchymal progenitor cells, generated using BioTimes PureStemtechnology, in regenerative medicine and will contrast the properties of those cells with adult-derived mesenchymal stem cells. He will also discuss how those cells can be utilized in the search for genes potentially useful in induced tissue regeneration (iTR). The presentation will be available on BioTimes website at http://www.biotimeinc.com/scientific-presentations.

MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine, August 19-21, 2013, is being held at the Cleveland Marriott Downtown at Key Center and is presented by Case Western Reserve University and the National Center for Regenerative Medicine.

About BioTime, Inc

BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTimes focus is on pluripotent stem cell technology based on human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of new therapeutic products. BioTimes therapeutic and research products include a wide array of proprietary PureStem progenitors, HyStem hydrogels, culture media, and differentiation kits. BioTime is developing Renevia (a HyStem product) as a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. In addition, BioTime has developed Hextend, a blood plasma volume expander for use in surgery, emergency trauma treatment and other applications. Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corporation under exclusive licensing agreements.

BioTime is also developing stem cell and other products for research, therapeutic, and diagnostic use through its subsidiaries:

Additional information about BioTime can be found on the web at http://www.biotimeinc.com.

Forward-Looking Statements

Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for BioTime and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, uncertainty in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of BioTime and its subsidiaries, particularly those mentioned in the cautionary statements found in BioTime's Securities and Exchange Commission filings. BioTime disclaims any intent or obligation to update these forward-looking statements.

To receive ongoing BioTime corporate communications, please click on the following link to join our email alert list: http://news.biotimeinc.com.

Read more:
BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine ...

What #39;s Stem Cell Therapy Dr Bill Johnson Has Answers
for more information go to... http://www.innovationstemcellcenter.com More useful info below... Drapeau #39;s theory that Adult Stem Cells are nothing less than the hum...

By: Mark Khan

Read this article:
What's Stem Cell Therapy Dr Bill Johnson Has Answers - Video

By: Jet Villa, InterAksyon.com August 18, 2013 5:02 PM

REUTERS FILE PHOTO

InterAksyon.com The online news portal of TV5

MANILA, Philippines - The Food and Drug Administration (FDA) will conduct on Friday, August 23, a public hearing on the regulation of stem cell therapy in the country.

The FDA said the public hearing is scheduled from 3 p.m. to 5 p,m, at the Audio-Visual Room, 3rd floor, Annex Building, FDA office on Civil Drive in Alabang Muntinlupa.

The purpose of the hearing is to discuss the regulation of stem cell therapy, the stem cell products, and the health facilities that are offering the service in the court, it said.

The FDA also established an online reporting system to document adverse events linked to human cells, tissues, and cellular- and tissue-based products such stem cell therapies acquired in any facility.

The agency said those who experienced any untoward event or side effect or treatment failures after undergoing stem cell procedures can report through FDA website at http://www.fda.gov.ph under eReport and Adverse Drug Reaction, Report section.

E-mails may also be sent toreport@fda.gov.ph.

All consumers are assuredthat all information given will be treated with utmost confidentiality.Contact details are needed in case of a need for follow-up and validation.However, anonymous reports will still be accepted, the FDA added.

See the rest here:
FDA hearing on stem cell therapy set on Friday, Aug. 23